Development and Validation of a Predictive Model for Maternal Cardiovascular Morbidity Events in Patients With Hypertensive Disorders of Pregnancy.

IF 4.6 2区 医学 Q1 ANESTHESIOLOGY
Marie-Louise Meng, Yuqi Li, Matthew Fuller, Quinn Lanners, Ashraf S Habib, Jerome J Federspiel, Johanna Quist-Nelson, Svati H Shah, Michael Pencina, Kim Boggess, Vijay Krishnamoorthy, Matthew Engelhard
{"title":"Development and Validation of a Predictive Model for Maternal Cardiovascular Morbidity Events in Patients With Hypertensive Disorders of Pregnancy.","authors":"Marie-Louise Meng, Yuqi Li, Matthew Fuller, Quinn Lanners, Ashraf S Habib, Jerome J Federspiel, Johanna Quist-Nelson, Svati H Shah, Michael Pencina, Kim Boggess, Vijay Krishnamoorthy, Matthew Engelhard","doi":"10.1213/ANE.0000000000007278","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Hypertensive disorders of pregnancy (HDP) are a major contributor to maternal morbidity, mortality, and accelerated cardiovascular (CV) disease. Comorbid conditions are likely important predictors of CV risk in pregnant people. Currently, there is no way to predict which people with HDP are at risk of acute CV complications. We developed and validated a predictive model for all CV events and for heart failure, renal failure, and cerebrovascular events specifically after HDP.</p><p><strong>Methods: </strong>Models were created using the Premier Healthcare Database. The inclusion criteria for the model dataset were delivery with an HDP with discharge from October 1, 2015 to December 31, 2020. Machine learning methods were used to derive predictive models of CV events occurring during delivery hospitalization (Index Model) or during readmission (Readmission Model) using a training set (60%) to estimate model parameters, a validation set (20%) to tune model hyperparameters and select a final model, and a test set (20%) to evaluate final model performance.</p><p><strong>Results: </strong>The total model cohort consisted of 553,658 deliveries with an HDP. A CV event occurred in 6501 (1.2%) of the delivery hospitalizations. Multilabel neural networks were selected for the Index Model and Readmission Model due to favorable performance compared to alternatives. This approach is designed for prediction of multiple events that share risk factors and may cooccur. The Index Model predicted all CV events with area under the receiver operating curve (AUROC) 0.878 and average precision (AP) 0.239 (cerebrovascular events: AUROC 0.941, heart failure: AUROC 0.898, and renal failure: AUROC 0.885). With a positivity threshold set to achieve ≥90% sensitivity, model specificity was 65.0%, 83.5%, 68.6%, and 65.6% for predicting all CV events, cerebrovascular events, heart failure, and renal failure, respectively. CV events within 1 year of delivery occurred in 3018 (0.6%) individuals. The Readmission Model predicted all CV events with AUROC 0.717 and AP 0.022 (renal failure: AUROC 0.748, heart failure: AUROC 0.734, and cerebrovascular events AUROC 0.698). Feature importance analysis indicated that the presence of chronic renal disease, cardiac disease, pulmonary hypertension, and preeclampsia with severe features had the greatest effect on the prediction of CV events.</p><p><strong>Conclusions: </strong>Among individuals with HDP, our multilabel neural network model predicted CV events at delivery admission with good classification and events within 1 year of delivery with fair classification.</p>","PeriodicalId":7784,"journal":{"name":"Anesthesia and analgesia","volume":" ","pages":""},"PeriodicalIF":4.6000,"publicationDate":"2024-11-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Anesthesia and analgesia","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1213/ANE.0000000000007278","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ANESTHESIOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Hypertensive disorders of pregnancy (HDP) are a major contributor to maternal morbidity, mortality, and accelerated cardiovascular (CV) disease. Comorbid conditions are likely important predictors of CV risk in pregnant people. Currently, there is no way to predict which people with HDP are at risk of acute CV complications. We developed and validated a predictive model for all CV events and for heart failure, renal failure, and cerebrovascular events specifically after HDP.

Methods: Models were created using the Premier Healthcare Database. The inclusion criteria for the model dataset were delivery with an HDP with discharge from October 1, 2015 to December 31, 2020. Machine learning methods were used to derive predictive models of CV events occurring during delivery hospitalization (Index Model) or during readmission (Readmission Model) using a training set (60%) to estimate model parameters, a validation set (20%) to tune model hyperparameters and select a final model, and a test set (20%) to evaluate final model performance.

Results: The total model cohort consisted of 553,658 deliveries with an HDP. A CV event occurred in 6501 (1.2%) of the delivery hospitalizations. Multilabel neural networks were selected for the Index Model and Readmission Model due to favorable performance compared to alternatives. This approach is designed for prediction of multiple events that share risk factors and may cooccur. The Index Model predicted all CV events with area under the receiver operating curve (AUROC) 0.878 and average precision (AP) 0.239 (cerebrovascular events: AUROC 0.941, heart failure: AUROC 0.898, and renal failure: AUROC 0.885). With a positivity threshold set to achieve ≥90% sensitivity, model specificity was 65.0%, 83.5%, 68.6%, and 65.6% for predicting all CV events, cerebrovascular events, heart failure, and renal failure, respectively. CV events within 1 year of delivery occurred in 3018 (0.6%) individuals. The Readmission Model predicted all CV events with AUROC 0.717 and AP 0.022 (renal failure: AUROC 0.748, heart failure: AUROC 0.734, and cerebrovascular events AUROC 0.698). Feature importance analysis indicated that the presence of chronic renal disease, cardiac disease, pulmonary hypertension, and preeclampsia with severe features had the greatest effect on the prediction of CV events.

Conclusions: Among individuals with HDP, our multilabel neural network model predicted CV events at delivery admission with good classification and events within 1 year of delivery with fair classification.

妊娠期高血压疾病患者孕产妇心血管发病率预测模型的开发与验证。
背景:妊娠期高血压疾病(HDP)是导致孕产妇发病、死亡和加速心血管(CV)疾病的主要因素。合并症可能是预测妊娠期心血管疾病风险的重要因素。目前,还没有办法预测哪些 HDP 患者有发生急性心血管并发症的风险。我们开发并验证了一个针对所有 CV 事件以及 HDP 后心衰、肾衰和脑血管事件的预测模型:方法:使用 Premier Healthcare 数据库创建模型。模型数据集的纳入标准为 2015 年 10 月 1 日至 2020 年 12 月 31 日出院的 HDP 患者。使用训练集(60%)估算模型参数,使用验证集(20%)调整模型超参数并选择最终模型,使用测试集(20%)评估最终模型性能:模型队列共包括 553,658 例有 HDP 的分娩。在6501例(1.2%)住院分娩中发生了CV事件。与其他方法相比,多标签神经网络具有良好的性能,因此被选为指数模型和再入院模型。这种方法专为预测具有共同风险因素并可能同时发生的多种事件而设计。指数模型预测所有 CV 事件的接收者操作曲线下面积(AUROC)为 0.878,平均精度(AP)为 0.239(脑血管事件:AUROC 0.941,AP 0.239):脑血管事件:AUROC 0.941;心力衰竭:AUROC 0.898;心肌梗死:AUROC 0.941脑血管事件:AUROC 0.941;心力衰竭:AUROC 0.898;肾衰竭:AUROC 0.885):AUROC 0.885)。在灵敏度≥90%的阳性阈值设定下,预测所有心血管事件、脑血管事件、心力衰竭和肾衰竭的模型特异性分别为 65.0%、83.5%、68.6% 和 65.6%。分娩后 1 年内发生心血管事件的人数为 3018 人(0.6%)。再入院模型预测所有心血管事件的 AUROC 为 0.717,AP 为 0.022(肾衰竭:AUROC 为 0.748,AP 为 0.022):肾衰竭:AUROC 0.748,心衰:AUROC 0.734,心衰:AUROC 0.022:肾衰竭:AUROC 0.748;心衰:AUROC 0.734;脑血管事件:AUROC 0.698)。特征重要性分析表明,存在慢性肾病、心脏病、肺动脉高压和先兆子痫等严重特征对预测心血管事件的影响最大:结论:在 HDP 患者中,我们的多标签神经网络模型可预测入院分娩时的心血管事件,分类效果良好;可预测分娩后 1 年内的心血管事件,分类效果一般。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Anesthesia and analgesia
Anesthesia and analgesia 医学-麻醉学
CiteScore
9.90
自引率
7.00%
发文量
817
审稿时长
2 months
期刊介绍: Anesthesia & Analgesia exists for the benefit of patients under the care of health care professionals engaged in the disciplines broadly related to anesthesiology, perioperative medicine, critical care medicine, and pain medicine. The Journal furthers the care of these patients by reporting the fundamental advances in the science of these clinical disciplines and by documenting the clinical, laboratory, and administrative advances that guide therapy. Anesthesia & Analgesia seeks a balance between definitive clinical and management investigations and outstanding basic scientific reports. The Journal welcomes original manuscripts containing rigorous design and analysis, even if unusual in their approach.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信